Developmental and Behavioral Pediatrics Clinical Studies

1 - 2 of 2

ML-004 for Adolescents and Adults With ASD

The purpose of this study is to test the safety of an investigational medicine called ML-004 and how it might affect communication, behavior, and other symptoms of autism spectrum disorder (ASD).  This medication is investigational because it has not been approved by the FDA for the treatment of symptoms associated with autism. 
You may qualify if you: 
  • Are 12 to 25 years old
  • Have an autism diagnosis
  • Have a designated care/study partner able to attend every visit and answer questions about the participant. This person does not need to be the participant's parent or guardian. This person should have significant contact with them and can support them for the duration of the study. 
  • Are able to swallow the study medication (tablet)

Camouflaging in Autism and Other Conditions

The primary objective of this study is to measure camouflaging behaviors (i.e., behaviors that hide autistic symptoms) and social compensation (i.e., behaviors that explicitly support social interaction) in individuals with and without ASD using an online self-report questionnaire - the CAT-Q.